Search

everythinglearnresearchcommunity

for

Search:↓

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

The study found that horizontal sections of scalp biopsies are better for analyzing hair loss, showing fewer hairs and more fine hairs in balding areas.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Cats with Feline Symmetrical Alopecia can regrow hair with proper treatment based on the specific cause, including diet, medication, or stress management.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.